TGFB1 and chronic kidney disease: For example, lovastatin slowed the progression of CKD by attenuating oxidative stress, modulating the TGF-β1/Smad signaling, and ameliorating the glomerular endothelial-to-mesenchymal transition in rats with diabetic nephropathy 83.